Molecule intelOpportunity: Lower0

Divalproex Sodium

71 brands · 33 companies · product forms

1 DRAP alert

Opportunity snapshot

Launch attractiveness
27
Market saturation
84
Price room
100
Regulatory risk
40
71
brands
33
companies
Rs 539.11
median price
97
price points
34.83x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 7%

Price room

Across observed sources and strengths
CheapestRs 69.5
MedianRs 539.11
Most expensiveRs 2,420.46
Spread34.83×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 34.83x across 97 trusted points (Rs 69.5-2420.46). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Divalproex Sodium — each links to its own medicine page.

Regulatory alerts

latest 2024-05-10
Drug Safety Alert: Risks associated with the use of Valproic Acid in Women and Girls of Ch

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(100) + 20% low-competition(16) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

33 canonical companies and 71 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 34.83x across 97 trusted points (Rs 69.5-2420.46). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2024-05-10.

Confidence

Reduced by: no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.